$23.04
+2.0%Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and Icelandic Skyr, a line of strained kefir and yogurt products; and frozen kefir in soft serve and pint-size containers. It sells its products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was founded in 1986 and is based in Morton Grove, Illinois.
Last Annual Value
13.86M
3-Year CAGR
147%
5-Year CAGR
34%
10-Year CAGR
22%
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Lifeway Foods, Inc. NASDAQ:LWAY | 13.86M | 6.8% | 33.2% | 14.8% | |
![]() B&G Foods, Inc. NYSE:BGS | -43.26M | N/A | N/A | N/A | |
![]() BRC Inc. NYSE:BRCC | -11.91M | N/A | N/A | N/A | |
![]() Mama's Creations, Inc. NASDAQ:MAMA | 5.29M | 31.9% | 5.4% | N/A | |
![]() Westrock Coffee Company, LLC NASDAQ:WEST | -90.10M | N/A | N/A | N/A | |
![]() USANA Health Sciences, Inc. NYSE:USNA | 10.76M | -44.7% | -37.9% | -20.0% | |
![]() Nature's Sunshine Products, Inc. NASDAQ:NATR | 19.52M | 9.0% | -7.5% | 24.7% | |
![]() Calavo Growers, Inc. NASDAQ:CVGW | 19.80M | N/A | N/A | -6.3% |
Continue your LWAY research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.